Table 3.

Hazard ratios for effect of clinicopathologic characteristics and the prevalence of TR in CD4+ T cells on overall survival

VariablesCategoriesUnivariate analysisMultivariate analysis
Overall survivalOverall survival
HR (95% CI)PHR (95% CI)P
Age (y)<60 vs ≥601.68 (0.88-3.22)0.121.30 (0.87-1.94)0.2
SexMale vs female1.03 (0.72-1.46)0.881.07 (0.73-1.56)0.74
Pathologic tumor statuspT1 + pT2 + pT3 vs pT41.16 (0.81-1.65)0.411.08 (0.72-1.56)0.71
Pathologic node statuspN0 vs pN1a + pN1b1.46 (1.00-2.12)0.048*1.97 (1.06-3.68)0.032*
Pathologic metastasis statuspM0 vs pM12.38 (1.34-4.24)0.0032*1.56 (1.01-2.40)0.045*
Tumor grade1 vs 2 + 32.19 (1.52-3.16)<0.0001*1.21 (0.60-2.44)0.6
Tumor margin statusNegative vs positive1.50 (1.05-2.14)0.026*1.67 (1.12-2.48)0.012*
Prevalence of TR in CD4+ T cellsLow vs high2.56 (1.77-3.70)<0.0001*2.45 (1.62-3.72)<0.0001*
  • Abbreviations: HR, hazard ratio; 95% CI, 95% confidence interval.

  • * Significant.

  • Tumors of special types of histology (adenosquamous cell carcinoma, etc.) are avoided.